세계의 폴리에틸렌 글리콜 시장 : 등급, 용도, 분자량, 원료, 최종사용자 산업, 지역별 예측(-2032년)

Global Polyethylene Glycol Market Research Report By Grade, By Application, By Molecular Weight, By Source, By End-Use Industry and By Regional Forecast to 2032

US $ 4,950 ￦ 6,864,000

PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다.

US $ 5,950 ￦ 8,251,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 기업 내 10명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능합니다.

US $ 7,250 ￦ 10,054,000

PDF & Excel (Enterprise License)

PDF, Excel 보고서를 동일 기업이 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste 가능하며, 인쇄 가능합니다.

한글목차

세계 폴리에틸렌 글리콜 시장 규모는 예측 기간 동안 6.55%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

의약품, 퍼스널케어 품목, 산업용도에 대한 수요 증가는 폴리에틸렌 글리콜 시장의 확대를 촉진할 것으로 예상됩니다. 인구 증가와 만성 질환의 유병률 증가는 산업을 촉진하고 의약품에 대한 수요를 증가시키는 주요 요인입니다.

또한, 신흥국의 가처분 소득이 증가함에 따라 퍼스널케어 용품에 대한 수요가 증가하고 있습니다. 폴리에틸렌 글리콜의 제조 기술 개발로 최근 폴리에틸렌 글리콜의 순도와 품질이 향상되고 있습니다. 또한, 식음료 산업에서 폴리에틸렌 글리콜을 사용하게 되면서 시장 확대의 새로운 전망이 열리고 있습니다.

제약 산업에서는 유연한 폴리머인 폴리에틸렌 글리콜을 의약품 조성물의 부형제로 널리 사용하고 있습니다. 주사제, 경구제, 외용제, 안정제, 용해제, 점도 조절제로 폴리에틸렌 글리콜을 사용하는 의약품은 일부에 불과합니다. 당뇨병 및 암과 같은 만성 질환의 유병률 증가는 폴리에틸렌 글리콜 기반 약물의 장기적인 치료를 필요로 하며, 제약 산업에서 폴리에틸렌 글리콜에 대한 수요 증가를 촉진하고 있습니다.

지역별 전망

북미는 2023년 시장 매출의 35% 이상으로 가장 큰 점유율을 차지할 것으로 예상됩니다. 폴리에틸렌 글리콜 수요를 주도하는 것은 이 지역의 탄탄한 퍼스널케어 산업과 제약 산업입니다. 또한, 유럽은 대규모 화학 및 제약 기업이 존재하기 때문에 북미에 이어 두 번째로 큰 시장 점유율을 차지하고 있습니다.

세계의 폴리에틸렌글리콜(Polyethylene Glycol) 시장을 조사했으며, 시장 정의와 개요, 시장 성장에 영향을 미치는 각종 영향요인 분석, 시장 규모 추이와 예측, 각종 부문별/지역별/주요 국가별 분석, 경쟁 환경, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

• 시장 개요
• 주요 조사 결과
• 시장 세분화
• 경쟁 구도
• 과제와 기회
• 향후 전망

제2장 시장 개요

제3장 조사 방법

제4장 시장 역학

• 개요
• 성장 촉진요인
• 성장 억제요인
• 기회

제5장 시장 요인 분석

• 밸류체인 분석
• Porter의 Five Forces 분석
• COVID-19의 영향 분석

제6장 폴리에틸렌 글리콜 시장 : 등급별

• 의약품 등급
• 산업 등급
• 화장품 등급
• 식품 등급

제7장 폴리에틸렌 글리콜 시장 : 용도별

• 의약품
• 화장품 및 퍼스널케어
• 식품 및 음료
• 산업용 용제
• 섬유 마무리

제8장 폴리에틸렌 글리콜 시장 : 분자량별

• 200-400g/mol
• 400-600g/mol
• 600-1,000g/mol
• 1,000-2,000g/mol
• 2,000g/mol 이상

제9장 폴리에틸렌 글리콜 시장 : 원료별

• 에틸렌옥사이드
• 이염화에틸렌
• 에틸렌글리콜

제10장 폴리에틸렌 글리콜 시장 : 최종사용자 산업별

• 의료기기
• 의약품 포장
• 윤활유 첨가제
• 종이 코팅

제11장 폴리에틸렌 글리콜 시장 : 지역별

• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 프랑스
  • 러시아
  • 이탈리아
  • 스페인
  • 기타
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 한국
  • 말레이시아
  • 태국
  • 인도네시아
  • 기타
• 남미
  • 브라질
  • 멕시코
  • 아르헨티나
  • 기타
• 중동 및 아프리카
  • GCC 국가
  • 남아프리카공화국
  • 기타

제12장 경쟁 구도

• 개요
• 경쟁 분석
• 시장 점유율 분석
• 주요 성장 전략
• 경쟁 벤치마킹
• 개발 건수 기준 주요 기업
• 주요 발전과 성장 전략
• 주요 기업의 재무 매트릭스

제13장 기업 개요

• SABIC
• SINOPEC GROUP
• BRASKEM
• CELANESE CORPORATION
• CHINA NATIONAL CHEMICAL CORPORATION
• MITSUBISHI CHEMICAL HOLDINGS CORPORATION
• EXXONMOBIL
• LYONDELLBASELL INDUSTRIES HOLDINGS B.V.
• LG CHEM
• FORMOSA PLASTICS CORPORATION
• HUNTSMAN CORPORATION
• INEOS GROUP LIMITED
• DOW CHEMICAL COMPANY
• MITSUBISHI CHEMICAL CORPORATION
• BASF

제14장 부록

LSH

영문 목차

영문목차

Global Polyethylene Glycol Market Research Report By Grade (Pharmaceutical Grade, Industrial Grade, Cosmetic Grade, Food Grade), By Application (Pharmaceuticals, Cosmetics and Personal Care, Food and Beverages, Industrial Solvents, Textile Finishing), By Molecular Weight (200-400 g/mol, 400-600 g/mol, 600-1000 g/mol, 1000-2000 g/mol, Above 2000 g/mol), By Source (Ethylene Oxide, Ethylene Dichloride, Ethylene Glycol), By End-Use Industry (Medical Device, Pharmaceutical Packaging, Lubricant Additive, Paper Coating) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) Forecast to 2032

Overview of the Market

The Polyethylene Glycol Market's annual growth rate (CAGR) is anticipated to be approximately 6.55% over the course of the forecast period, according to MRFR analysis.

The growing need for medicines, personal care items, and industrial applications is expected to propel the polyethylene glycol market's expansion. The growing population and the rising incidence of chronic illnesses are major factors propelling the industry and raising demand for pharmaceuticals.

Furthermore, the demand for personal care goods is being fueled by emerging economies' growing disposable income. Technological developments in the manufacturing of polyethylene glycol have led to increased purity and better qualities in recent years. Furthermore, new prospects for market expansion are being created by the food and beverage industry's growing use of polyethylene glycol.

The pharmaceutical industry uses polyethylene glycol (PEG), a flexible polymer, extensively as an excipient in medicinal compositions. Injectables, oral drugs, and topical formulations are just a few of the pharmaceutical products that use PEG as a stabilizer, solubilizer, and viscosity modifier. The rising incidence of chronic illnesses like diabetes and cancer, which call for long-term therapy with PEG-based drugs, is fueling the pharmaceutical industry's expanding need for PEG.

Perspectives on Market Segments

Pharmaceutical, industrial, cosmetic, and food grades are the divisions of the global polyethylene glycol (PEG) market.

Pharmaceuticals, Cosmetics and Personal Care, Food and Beverages, Industrial Solvents, and Textile Finishing are the market's application-based divisions.

Five molecular weight ranges are used to segment the polyethylene glycol market: 200-400 g/mol, 400-600 g/mol, 600-1000 g/mol, 1000-2000 g/mol, and over 2000 g/mol. Every segment has its own growth patterns and serves end-use industries.

The market is divided into three segments based on the source: ethylene glycol, ethylene dichloride, and ethylene oxide.

The Polyethylene Glycol Market's revenue, segmentation, data, statistics, and industry growth are significantly influenced by the end-use industry segment.

Regional Perspectives

Understanding the dynamics and future potential of the polyethylene glycol market depends heavily on its regional segmentation. The main geographies examined in this research are North America, Europe, APAC, South America, and MEA. With over 35% of the Polyethylene Glycol Market's revenue in 2023, North America accounted for the highest market share. The demand for polyethylene glycol is driven by the region's robust personal care and pharmaceutical industries. Because of the existence of large chemical and pharmaceutical businesses, Europe has a huge market share that is second only to North America. According to projections, PAC will increase at the fastest rate till 2032.

Key Players

ExxonMobil, LyondellBasell Industries Holdings B.V., LG Chem, Formosa Plastics Corporation, Huntsman Corporation, Ineos Group Limited, Dow Chemical Company, Mitsubishi Chemical Holdings Corporation, China National Chemical Corporation, SABIC, Sinopec Group, Braskem, Celanese Corporation, and BASF are important players in the polyethylene glycol market.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

• 1.1. MARKET OVERVIEW
• 1.2. KEY FINDINGS
• 1.3. MARKET SEGMENTATION
• 1.4. COMPETITIVE LANDSCAPE
• 1.5. CHALLENGES AND OPPORTUNITIES
• 1.6. FUTURE OUTLOOK

2. MARKET INTRODUCTION

• 2.1. DEFINITION
• 2.2. SCOPE OF THE STUDY
  • 2.2.1. RESEARCH OBJECTIVE
  • 2.2.2. ASSUMPTION
  • 2.2.3. LIMITATIONS

3. RESEARCH METHODOLOGY

• 3.1. OVERVIEW
• 3.2. DATA MINING
• 3.3. SECONDARY RESEARCH
• 3.4. PRIMARY RESEARCH
  • 3.4.1. PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
  • 3.4.2. BREAKDOWN OF PRIMARY RESPONDENTS
• 3.5. FORECASTING MODEL
• 3.6. MARKET SIZE ESTIMATION
  • 3.6.1. BOTTOM-UP APPROACH
  • 3.6.2. TOP-DOWN APPROACH
• 3.7. DATA TRIANGULATION
• 3.8. VALIDATION

4. MARKET DYNAMICS

• 4.1. OVERVIEW
• 4.2. DRIVERS
• 4.3. RESTRAINTS
• 4.4. OPPORTUNITIES

5. MARKET FACTOR ANALYSIS

• 5.1. VALUE CHAIN ANALYSIS
• 5.2. PORTER'S FIVE FORCES ANALYSIS
  • 5.2.1. BARGAINING POWER OF SUPPLIERS
  • 5.2.2. BARGAINING POWER OF BUYERS
  • 5.2.3. THREAT OF NEW ENTRANTS
  • 5.2.4. THREAT OF SUBSTITUTES
  • 5.2.5. INTENSITY OF RIVALRY
• 5.3. COVID-19 IMPACT ANALYSIS
  • 5.3.1. MARKET IMPACT ANALYSIS
  • 5.3.2. REGIONAL IMPACT
  • 5.3.3. OPPORTUNITY AND THREAT ANALYSIS

6. POLYETHYLENE GLYCOL MARKET, BY GRADE (USD BILLION)

• 6.1. PHARMACEUTICAL GRADE
• 6.2. INDUSTRIAL GRADE
• 6.3. COSMETIC GRADE
• 6.4. FOOD GRADE

7. POLYETHYLENE GLYCOL MARKET, BY APPLICATION (USD BILLION)

• 7.1. PHARMACEUTICALS
• 7.2. COSMETICS AND PERSONAL CARE
• 7.3. FOOD AND BEVERAGES
• 7.4. INDUSTRIAL SOLVENTS
• 7.5. TEXTILE FINISHING

8. POLYETHYLENE GLYCOL MARKET, BY MOLECULAR WEIGHT (USD BILLION)

• 8.1. 200-400 G/MOL
• 8.2. 400-600 G/MOL
• 8.3. 600-1000 G/MOL
• 8.4. 1000-2000 G/MOL
• 8.5. ABOVE 2000 G/MOL

9. POLYETHYLENE GLYCOL MARKET, BY SOURCE (USD BILLION)

• 9.1. ETHYLENE OXIDE
• 9.2. ETHYLENE DICHLORIDE
• 9.3. ETHYLENE GLYCOL

10. POLYETHYLENE GLYCOL MARKET, BY END-USE INDUSTRY (USD BILLION)

• 10.1. MEDICAL DEVICE
• 10.2. PHARMACEUTICAL PACKAGING
• 10.3. LUBRICANT ADDITIVE
• 10.4. PAPER COATING

11. POLYETHYLENE GLYCOL MARKET, BY REGIONAL (USD BILLION)

• 11.1. NORTH AMERICA
  • 11.1.1. US
  • 11.1.2. CANADA
• 11.2. EUROPE
  • 11.2.1. GERMANY
  • 11.2.2. UK
  • 11.2.3. FRANCE
  • 11.2.4. RUSSIA
  • 11.2.5. ITALY
  • 11.2.6. SPAIN
  • 11.2.7. REST OF EUROPE
• 11.3. APAC
  • 11.3.1. CHINA
  • 11.3.2. INDIA
  • 11.3.3. JAPAN
  • 11.3.4. SOUTH KOREA
  • 11.3.5. MALAYSIA
  • 11.3.6. THAILAND
  • 11.3.7. INDONESIA
  • 11.3.8. REST OF APAC
• 11.4. SOUTH AMERICA
  • 11.4.1. BRAZIL
  • 11.4.2. MEXICO
  • 11.4.3. ARGENTINA
  • 11.4.4. REST OF SOUTH AMERICA
• 11.5. MEA
  • 11.5.1. GCC COUNTRIES
  • 11.5.2. SOUTH AFRICA
  • 11.5.3. REST OF MEA

12. COMPETITIVE LANDSCAPE

• 12.1. OVERVIEW
• 12.2. COMPETITIVE ANALYSIS
• 12.3. MARKET SHARE ANALYSIS
• 12.4. MAJOR GROWTH STRATEGY IN THE POLYETHYLENE GLYCOL MARKET
• 12.5. COMPETITIVE BENCHMARKING
• 12.6. LEADING PLAYERS IN TERMS OF NUMBER OF DEVELOPMENTS IN THE POLYETHYLENE GLYCOL MARKET
• 12.7. KEY DEVELOPMENTS AND GROWTH STRATEGIES
  • 12.7.1. NEW PRODUCT LAUNCH/SERVICE DEPLOYMENT
  • 12.7.2. MERGER & ACQUISITIONS
  • 12.7.3. JOINT VENTURES
• 12.8. MAJOR PLAYERS FINANCIAL MATRIX
  • 12.8.1. SALES AND OPERATING INCOME
  • 12.8.2. MAJOR PLAYERS R&D EXPENDITURE.

13. COMPANY PROFILES

• 13.1. SABIC
  • 13.1.1. FINANCIAL OVERVIEW
  • 13.1.2. PRODUCTS OFFERED
  • 13.1.3. KEY DEVELOPMENTS
  • 13.1.4. SWOT ANALYSIS
  • 13.1.5. KEY STRATEGIES
• 13.2. SINOPEC GROUP
  • 13.2.1. FINANCIAL OVERVIEW
  • 13.2.2. PRODUCTS OFFERED
  • 13.2.3. KEY DEVELOPMENTS
  • 13.2.4. SWOT ANALYSIS
  • 13.2.5. KEY STRATEGIES
• 13.3. BRASKEM
  • 13.3.1. FINANCIAL OVERVIEW
  • 13.3.2. PRODUCTS OFFERED
  • 13.3.3. KEY DEVELOPMENTS
  • 13.3.4. SWOT ANALYSIS
  • 13.3.5. KEY STRATEGIES
• 13.4. CELANESE CORPORATION
  • 13.4.1. FINANCIAL OVERVIEW
  • 13.4.2. PRODUCTS OFFERED
  • 13.4.3. KEY DEVELOPMENTS
  • 13.4.4. SWOT ANALYSIS
  • 13.4.5. KEY STRATEGIES
• 13.5. CHINA NATIONAL CHEMICAL CORPORATION
  • 13.5.1. FINANCIAL OVERVIEW
  • 13.5.2. PRODUCTS OFFERED
  • 13.5.3. KEY DEVELOPMENTS
  • 13.5.4. SWOT ANALYSIS
  • 13.5.5. KEY STRATEGIES
• 13.6. MITSUBISHI CHEMICAL HOLDINGS CORPORATION
  • 13.6.1. FINANCIAL OVERVIEW
  • 13.6.2. PRODUCTS OFFERED
  • 13.6.3. KEY DEVELOPMENTS
  • 13.6.4. SWOT ANALYSIS
  • 13.6.5. KEY STRATEGIES
• 13.7. EXXONMOBIL
  • 13.7.1. FINANCIAL OVERVIEW
  • 13.7.2. PRODUCTS OFFERED
  • 13.7.3. KEY DEVELOPMENTS
  • 13.7.4. SWOT ANALYSIS
  • 13.7.5. KEY STRATEGIES
• 13.8. LYONDELLBASELL INDUSTRIES HOLDINGS B.V.
  • 13.8.1. FINANCIAL OVERVIEW
  • 13.8.2. PRODUCTS OFFERED
  • 13.8.3. KEY DEVELOPMENTS
  • 13.8.4. SWOT ANALYSIS
  • 13.8.5. KEY STRATEGIES
• 13.9. LG CHEM
  • 13.9.1. FINANCIAL OVERVIEW
  • 13.9.2. PRODUCTS OFFERED
  • 13.9.3. KEY DEVELOPMENTS
  • 13.9.4. SWOT ANALYSIS
  • 13.9.5. KEY STRATEGIES
• 13.10. FORMOSA PLASTICS CORPORATION
  • 13.10.1. FINANCIAL OVERVIEW
  • 13.10.2. PRODUCTS OFFERED
  • 13.10.3. KEY DEVELOPMENTS
  • 13.10.4. SWOT ANALYSIS
  • 13.10.5. KEY STRATEGIES
• 13.11. HUNTSMAN CORPORATION
  • 13.11.1. FINANCIAL OVERVIEW
  • 13.11.2. PRODUCTS OFFERED
  • 13.11.3. KEY DEVELOPMENTS
  • 13.11.4. SWOT ANALYSIS
  • 13.11.5. KEY STRATEGIES
• 13.12. INEOS GROUP LIMITED
  • 13.12.1. FINANCIAL OVERVIEW
  • 13.12.2. PRODUCTS OFFERED
  • 13.12.3. KEY DEVELOPMENTS
  • 13.12.4. SWOT ANALYSIS
  • 13.12.5. KEY STRATEGIES
• 13.13. DOW CHEMICAL COMPANY
  • 13.13.1. FINANCIAL OVERVIEW
  • 13.13.2. PRODUCTS OFFERED
  • 13.13.3. KEY DEVELOPMENTS
  • 13.13.4. SWOT ANALYSIS
  • 13.13.5. KEY STRATEGIES
• 13.14. MITSUBISHI CHEMICAL CORPORATION
  • 13.14.1. FINANCIAL OVERVIEW
  • 13.14.2. PRODUCTS OFFERED
  • 13.14.3. KEY DEVELOPMENTS
  • 13.14.4. SWOT ANALYSIS
  • 13.14.5. KEY STRATEGIES
• 13.15. BASF
  • 13.15.1. FINANCIAL OVERVIEW
  • 13.15.2. PRODUCTS OFFERED
  • 13.15.3. KEY DEVELOPMENTS
  • 13.15.4. SWOT ANALYSIS
  • 13.15.5. KEY STRATEGIES

14. APPENDIX

• 14.1. REFERENCES
• 14.2. RELATED REPORTS

관련자료